Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Strategies to Improve the Safety of iPSC-Derived β Cells for β Cell Replacement in Diabetes

24 Aug 2022

Abstract excerpt

Allogeneic islet transplantation allows for the re-establishment of glycemic control with the possibility of insulin independence, but is severely limited by the scarcity of organ donors. However, a new source of insulin-producing cells could enable the widespread use of cell therapy for diabetes treatment. Recent breakthroughs in stem cell biology, particularly pluripotent stem cell (PSC) techniques, have...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Genetics and Neurodevelopmental Disorders
Share to Pancreatic function and diabetes
Share to Pluripotent Stem Cells Research

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 36090777
DOI: 10.3389/ti.2022.10575

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Strategies to Improve the Safety of iPSC-Derived β Cells for β Cell Replacement in DiabetesPMID 36090777Read ↗

Characterization of stem-cell-derived islets during differentiation and after implantationSemantic proximity Read ↗

The prospect of induced pluripotent stem cells for diabetes mellitus treatmentSemantic proximity Read ↗

Converting human pluripotent stem cells into β-cells: recent advances and future challengesSemantic proximity Read ↗

Generation of β cells from human pluripotent stem cells: Are we there yet?Semantic proximity Read ↗

The potential and challenges of alternative sources of β cells for the cure of type 1 diabetesSemantic proximity Read ↗

Tumor-Free Transplantation of Patient-Derived Induced Pluripotent Stem Cell Progeny for Customized Islet Regeneration.Semantic proximity Read ↗

Stem cell approaches for diabetes: towards beta cell replacementSemantic proximity Read ↗

Stepwise differentiation of functional pancreatic β cells from human pluripotent stem cellsSemantic proximity Read ↗

Applications of iPSC-derived beta cells from patients with diabetesSemantic proximity Read ↗

Concise Review: Pluripotent Stem Cell-Based Regenerative Applications for Failing β-Cell FunctionSemantic proximity Read ↗

Towards a Functional Cure for Diabetes Using Stem Cell-Derived Beta Cells: Are We There Yet?Semantic proximity Read ↗

Pancreatic Stem Cells Remain UnresolvedSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.